Login to Your Account



Lexicon '110 percent ready' to move first approval to market

By Marie Powers
News Editor

Wednesday, March 1, 2017

Lexicon Pharmaceuticals Inc. plans to deploy its sales force Friday and have its first approved product, Xermelo (telotristat ethyl, previously LX-1032/LX-1606), available Monday for dispensing through its specialty pharmacies following the oral drug's approval by the FDA to treat carcinoid syndrome diarrhea in patients living with metastatic neuroendocrine tumors, or mNETs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription